BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24854146)

  • 1. Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation.
    Ogul H; Karaca L; Pirimoglu B; Aydinli B; Kantarci M
    Acta Neurol Belg; 2015 Mar; 115(1):75-6. PubMed ID: 24854146
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy.
    Yilmaz S; Gokben S; Arikan C; Calli C; Serdaroglu G
    Pediatr Neurol; 2010 Nov; 43(5):359-62. PubMed ID: 20933182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus leukoencephalopathy--is it posterior reversible encephalopathy syndrome?
    Zhang HL
    Pediatr Neurol; 2011 Mar; 44(3):236; author reply 236. PubMed ID: 21310344
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukoencephalopathy syndrome after living-donor liver transplantation.
    Umeda Y; Matsuda H; Sadamori H; Shinoura S; Yoshida R; Sato D; Utsumi M; Yagi T; Fujiwara T
    Exp Clin Transplant; 2011 Apr; 9(2):139-44. PubMed ID: 21453233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Posterior reversible encephalopathy related to tacrolimus in a liver transplanted HIV patient].
    Courand PY; Christin F; Ben Cheikh A; Baillon JJ; Ber CE; Rimmelé T
    Gastroenterol Clin Biol; 2010 Jan; 34(1):29-34. PubMed ID: 19781881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation.
    Sato K; Miura Y; Marui Y; Tanaka K; Tomikawa S
    Int Urol Nephrol; 2015 Aug; 47(8):1437-8. PubMed ID: 26071870
    [No Abstract]   [Full Text] [Related]  

  • 7. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation.
    Frühauf NR; Koeppen Dagger S; Saner FH; Egelhof Dagger T; Stavrou G; Nadalin S; Broelsch CE
    Liver Transpl; 2003 Sep; 9(9):983-5. PubMed ID: 12942462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous busulfan-induced reversible leukoencephalopathy syndrome.
    Nakazato T; Sanada Y; Mihara A; Aisa Y
    Ann Hematol; 2011 Dec; 90(12):1491-2. PubMed ID: 21380510
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis.
    Smeralda CL; Gigli GL; Vogrig A; Marini A; Valente M
    J Neuroimmunol; 2019 May; 330():55-58. PubMed ID: 30825860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central pontine myelinolysis after living donor liver transplantation].
    Matsusaki T; Morimatsu H; Sato T; Sato K; Matsumi M; Morita K
    Masui; 2008 Sep; 57(9):1136-8. PubMed ID: 18807901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506).
    Small SL; Fukui MB; Bramblett GT; Eidelman BH
    Ann Neurol; 1996 Oct; 40(4):575-80. PubMed ID: 8871576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gout in liver transplant patients receiving tacrolimus.
    Gerster JC; Dudler M; Halkic N; Gillet M
    Ann Rheum Dis; 2004 Jul; 63(7):894-5. PubMed ID: 15194597
    [No Abstract]   [Full Text] [Related]  

  • 13. A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation.
    Jacobwitz M; Burstein D; Sotardi S; Maeda K; Beslow LA
    J Heart Lung Transplant; 2022 Nov; 41(11):1653-1655. PubMed ID: 36085272
    [No Abstract]   [Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.
    Lunardi N; Saraceni E; Boccagni P; Segato M; Bortolato A; Manara R; Rossi S; Ori C
    Minerva Anestesiol; 2012 Jul; 78(7):847-50. PubMed ID: 21701444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden hearing loss associated with tacrolimus in a liver transplant recipient.
    Norman K; Bonatti H; Dickson RC; Aranda-Michel J
    Transpl Int; 2006 Jul; 19(7):601-3. PubMed ID: 16764642
    [No Abstract]   [Full Text] [Related]  

  • 16. A Case Report of Drug-Induced Thrombocytopenia after Living Donor Liver Transplantation.
    Arai K; Kuramitsu K; Fukumoto T; Kido M; Takebe A; Tanaka M; Kinoshita H; Ajiki T; Toyama H; Asari S; Goto T; Ku Y
    Kobe J Med Sci; 2016 Jun; 62(1):E9-E12. PubMed ID: 27492209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus and food allergy.
    Pacifico L; Frediani T; Simonetti A; Chiesa C; Cucchiara S
    Transplantation; 2003 Dec; 76(12):1778. PubMed ID: 14688538
    [No Abstract]   [Full Text] [Related]  

  • 18. Central retinal vein occlusion-associated tacrolimus after liver transplantation.
    Donnadieu B; Amouyal F; Hoffart L; Matonti F
    Transplantation; 2014 Dec; 98(12):e94-5. PubMed ID: 25955343
    [No Abstract]   [Full Text] [Related]  

  • 19. PRES: clinical evidence or incidental finding?
    Carassiti M; Antonelli S
    Minerva Anestesiol; 2013 Jun; 79(6):701. PubMed ID: 23174927
    [No Abstract]   [Full Text] [Related]  

  • 20. [The prevention and management of cerebrovascular complications in nine cases after orthotopic liver transplantation].
    Qian SK; He XS; Zhu XF; Ma Y; Wang DP; Ju WQ; Wu LW; Zhang XL; Yu XB
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):860-1. PubMed ID: 16313741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.